Primary information |
---|
sequence ID | Seq_1075 |
Peptide sequence | DAAYMNKV |
CancerPDF_ID | CancerPDF_ID11336, CancerPDF_ID12649, |
PMID | 26992070,26992070 |
Protein Name | "Keratin, type II cytoskeletal 5","Keratin, type II cytoskeletal 5" |
UniprotKB Entry Name | K2C5_HUMAN,HBB_HUMAN |
Fluid | Serum,Serum |
M/Z | NA,NA |
Charge | NA,NA |
Mass (in Da) | 911.4280871,927.4221057 |
fdr | NA,NA |
Profiling Technique | LC-MS,LC-MS |
Peptide Identification technique | LC-MS/MS,LC-MS/MS |
Quantification Technique | NA,NA |
Labelled/Label Free | Label Free,Label Free |
FDR | FDR 1 %,FDR 1 % |
CancerPDF_ID | CancerPDF_ID11336, CancerPDF_ID12649, |
p-Value | NA,NA |
Software | SEQUEST and Maxquant,"Maxquant,Proteome Discoverer" |
Length | 8,8 |
Cancer Type | Melanoma,Melanoma |
Database | SwissProt Database,SwissProt Database |
Modification | NA,NA |
Number of Patients | 8 cancer samples and 4 healthy samples,8 cancer samples and 4 healthy samples |
Regulation | "Present in 2 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples.","Present in 2 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." |
Validation | na,NA |
Sensitivity | NA,NA |
Specificity | NA,NA |
Accuracy | NA,NA |
Peptide Atlas | NA |
IEDB | |